Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy
Recruiting · NCT07375069 · Observational (researchers observe without assigning treatment) · Lead sponsor: Federico II University
View the official record on ClinicalTrials.gov →Interventions studied
data collection
What this trial is about
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 18 years;
- Diagnosis of type 2 diabetes mellitus (T2DM);
- Stable clinical conditions
- Outpatient settings
- Ability to understand the study procedures and provide written informed consent.
Exclusion criteria
- Patients with type 1 diabetes mellitus;
- Active participation in interventional studies;
- Any condition that may put the patient at risk by participating in the study.
Where it is running
1 location listed.
- Federico II University of Naples, Department of Advanced Biomedical Sciences - Naples, Napoli, Italy